Forbes 12 May 2020

How To Fast-Track A COVID-19 Vaccine - Steve Forbes


Steve Forbes on why creating a $50 billion vaccine prize would speed up breakthrough science and incentivize a coronavirus cure, and why funding the challenge is a small price to pay, given the pandemic's immense human and economic costs.

Let Steve know what's on your mind and any topics you'd like to see covered in future episodes!

What's Ahead featuring Steve Forbes provides his insights and perspective, to stay on top of what's happening in this ever-turbulent world with glimpses into the future. What's Ahead airs Tuesdays, Thursdays and Fridays at 9am.
#SteveForbes #WhatsAhead

New York City has a long history of fighting back against disease. But it took a while for the city to learn how. Here is a look at how several 19th century disease outbreaks helped prepare NYC for diseases like the 1918 Spanish Flu and, eventually, COVID-19.
The federal government has launched a website and phone number where Canadians facing unemployment due to the COVID-19 crisis can apply for emergency income support benefits.

Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, says a small vaccine trial by a U.S. company has passed some preliminary hurdles, but notes "it's very, very early" on the path to finding a safe COVID-19 vaccine.

American pharmaceutical giant Johnson & Johnson is fast-tracking its most promising COVID-19 vaccine and expects to have it out by January 2021 for emergency applications. But questions linger as to whether it would be made available to everyone.

CGTN's Karina Huber explains.

Share Video:

Embed Video: